Symposium Body Control – Legal Regulatory Perspectives on Biometrics and Biobanks 22-23 November 2007

ELSA-research initiated by the Research Council of Norway (RCN)

Senior adviser Helge Rynning, Division for strategic priorites, RCN

ELSA RESEARCH - RCN

- Ethical, legal and social aspects of biotechnology (ELSA – Norway); 2002-2007

- Functional genomics in Norway (FUGE) - Nanotechnology and new materials,

nanoscience and integration (NANOMAT) Ethical, legal and social aspects of

biotechnology, nanotechnology and cognitive science (2007-2012)

ELSA II (2007-2012)

Planning group, report June 2007

Steering Committee appointed, international profile

Programme plan Spring 2008

Planning group, research challenges

Science, technology and society Democracy, justice and power Language, dissemination,dialogue Governance and priorities Medicine and health: Prevention,

enhancement and design Food,environment and nature Privacy, consent Risk, precautionary principle

Programme Board

(Chair) Geir Gogstad, Ph.D.; Department Head, Rikshospitalet-Radiumhospitalet Medical Centre

Professor Peter Aleström, Norwegian School of Veterinary Science

Professor Rigmor Austgulen, Norwegian University of Science and Technology (NTNU)

Professor Ruth Chadwick, Cardiff University; Director of CESAGen (Centre for Economic and Social Aspects of Genomics), Wales

Professor Richard A.L. Jones, University of Sheffield, England

Programme Board (cont)

Fabrice Lapique, Research Manager, SINTEF Materials and Chemistry

Professor Arie Rip, University of Twente, The Netherlands

Associate Professor Andreas Roepstorff, University of Århus, Denmark

Professor Henriette Sinding Aasen, University of Bergen

Dr. Ilina Singh, London School of Economics and Political Science, England